e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pathogenesis of diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oxidative modification of proteins of blood plasma in patients with interstitial lung diseases
R. Bakenova, L. Muravlyeva, A. Baigenzhin, S. Tuganbekova (Astana, Karaganda, Kazakhstan)
Source:
Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Session:
Pathogenesis of diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
4188
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Bakenova, L. Muravlyeva, A. Baigenzhin, S. Tuganbekova (Astana, Karaganda, Kazakhstan). Oxidative modification of proteins of blood plasma in patients with interstitial lung diseases. Eur Respir J 2010; 36: Suppl. 54, 4188
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Analysis of antioxidant proteins and oxidized proteins in BAL of patients with interstitial lung diseases
Source: Eur Respir J 2004; 24: Suppl. 48, 42s
Year: 2004
Serum heat shock protein 47 levels in patients with drug induced lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006
Neutrophils oxidative activity of patients with occupational lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 445s
Year: 2001
Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Peroxidation processes, cytokines, BALF and blood cytology in patients with occupational lung diseases and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 275s
Year: 2002
Elevated serum levels of oxidative stress biomarkers in patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
The level of MDA in BALF might reflect oxidative tissue damage in patients with mild MAC pulmonary disease.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias
Source: Eur Respir J 2003; 21: 232-240
Year: 2003
Role of systemic and muscle oxidative stress and cytokines in patients with lung cancer cachexia
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011
Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases
Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis
Year: 2008
Comparison of the neutrophils oxidative activity in patients with occupational lung diseases and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 119s
Year: 2003
Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Adhesive and oxidative functions of neutrophils in patients with occupational pulmonary diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 446s
Year: 2001
Decreased mitochondrial complex I activity in blood lymphocytes of patients with idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Cellular interactions in the pathogenesis of interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 102-114
Year: 2015
Oxidative stress as common mechanism of inflammation in chronic lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 344s
Year: 2005
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept